Best Practices for Seeking Federal Funding for Biodefense
For life sciences companies seeking to develop products and technologies that are crucial to ensuring the safety of U.S. civilians or the U.S. armed forces, the federal government can be a source of non-dilutive funding. The U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DOD) frequently partner with organizations to develop new and innovative products and technologies to address chemical, biological, radiological and nuclear (CBRN) threats, influenza and emerging infectious diseases, in particular those with limited commercial viability that may otherwise hinder the development process.
While these funding opportunities are certainly attractive, the submission process can be daunting, especially for organizations new to partnering with the government. If you’re considering federal funding in the biodefense space, these best practices will help you put your best foot forward during the submission process.
SHARE